Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients

Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients

Abstract Background Luteinizing hormone-releasing hormone (LH-RH) agonists are the standard for androgen deprivation therapy (ADT) in prostate cancer (PCa) patients. Current guidelines recommend serum testosterone measurement to assess the efficacy of ADT and to define castration resistance. However...

Full description

Bibliographic Details
Main Authors: Juan Morote, Imma Comas, Roser Ferrer, Jacques Planas, Anna Celma, Lucas Regis
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Journal of Biomedical Science
Subjects:
Prostate cancer
Androgen deprivation therapy
LH-RH agonist
Testosterone
Luteinizing hormone
Online Access:http://link.springer.com/article/10.1186/s12929-017-0386-0

Internet

http://link.springer.com/article/10.1186/s12929-017-0386-0

Similar Items